Cervical cancer shot gains acceptance

Published: Oct. 10, 2008 at 7:04 PM
Order reprints
ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.

The 25.1 percent vaccination rate among 13- to 17-year-olds provides the first national estimate of use of Merck & Co.'s Gardasil vaccine, the Centers for Disease Control and Prevention said.

Gardasil, administered in a three-dose series, is a vaccine against certain types of human papillomavirus, which infects the skin and mucous membranes.

Human papillomavirus, or HPV, infection causes nearly all cases of cervical cancer, the second leading cause of death from cancer in women worldwide.

Nearly 4,000 women die of cervical cancer in the United States each year.

"For a new vaccine, 25 percent coverage is really very good," Immunization Services Director Lance Rodewald said.

Vaccine proponents had hoped for higher vaccination rates.

Both men and women can be HPV carriers. Studies are being conducted to determine the efficacy of vaccinating boys with Gardasil.


© 2008 United Press International, Inc. All Rights Reserved.



High court: Political ads on buses legal (1 min)
UPI NewsTrack Sports (6 min)
Boy, 12, allegedly raped schoolmate (7 min)
UPI NewsTrack TopNews (7 min)
Mickelson withdraws from British Open (12 min)
Grain futures close mixed (18 min)
Couple in Lisa Nowak case set to marry (18 min)
fark
Prospect Heights, Illinois Police Department HQ to close to the public on Fridays. Citizens are...
This sounds safe: 500,000 people with access to military weapons, all going through nicotine withdrawal...
"She's an opportunistic gold-digging attention whore," says opportunistic gold-digging attention...
Llost llamas llocated in Llouisville
2001: Teacher fired for sleeping with student. 2003: Hired again by same school. 2006: Fired again...
Drunk man on tractor leads police on wild, 40-minute chase at speeds up to 12 MPH